TuBerculosis Vaccine Initiative (TBVI)
TBVI is an independent non-profit foundation that facilitates the development of new vaccines to protect future generations against tuberculosis.
We financially support and bring expertise to an integrated network of over 50 universities, institutes and industries to develop more effective, safe vaccines that will be globally accessible and affordable. Research conducted by our mostly European based network has already resulted in promising vaccine discoveries.
New vaccines are urgently needed to stop tuberculosis. Every year almost 9 million new cases of this infectious disease are recorded. Every year around 1.5 million people die of TB, equaling one death every 22 seconds.
Summary in other languages: 
Our research projects
By linking the greatest research, TBVI increases the chances of finding the best solutions for tuberculosis. Read more ยป
World TB Day Symposium in Brussels
On 22 March TBVI organises a symposium in the European Parliament: "Europe and ACP together against TB".
Read more>>
News 
- 30.Nov.11 | World Aids day 2011: Want to...
- 23.Nov.11 | TB vaccine research: New...
- 01.Nov.11 | New TB roadmap emphasizes...
- 24.Oct.11 | TBVI at the 42nd World Union...
Events
- 15.Feb.12 | Symposium: Action on the...
- 22.Mar.12 | Symposium: Europe and ACP...
- 13.Apr.12 | International Conference on...
- 23.Apr.12 | Course: Clinical Vaccine...